TGF-βl Immunohistochemistry in Goiter: Comparison of Patients with Recurrence or No Recurrence
- 1 October 1996
- journal article
- research article
- Published by Mary Ann Liebert Inc in Thyroid®
- Vol. 6 (5), 417-422
- https://doi.org/10.1089/thy.1996.6.417
Abstract
The aim of this work was to establish whether the immunohistochemical pattern for TGF-β1 in goiters that recur after thyroid surgery is different when compared with goiters that do not recur postoperatively. Twelve goiters, surgically removed by partial resection between 1977 and 1982, were studied. Ten years after surgery, 6 patients had recurrence of goiter or thyroid nodules (group 1); the others did not have any recurrence (group 2). The presence and location of TGF-β1 were evaluated a posteriori by immunohistochemistry in histological samples of the tissue that was removed. In each goiter specimen, 50 randomly selected subcapsular follicles were studied to evaluate the percentage of follicles negative or positive for TGF-β1 and the protein's intrathyrocyte location. In the slides of group 1, the percentage of TGF-β1-positive follicles was statistically (p < 0.01) greater (93.1%) than in group 2 (71.4%). No difference in the location of TGF-β1 was found. The authors found a greater percentage of positive follicles for the TGF-β1 protein in group 1 patients. In conclusion, TGF-β1 production in goiter is variable, time dependent, and may be a marker of active cellular proliferation due to chronic exposure to a goitrogen stimulus. Thus, the more TGF-β1 found, the more the cell is stimulated and, therefore, the greater the risk of relapse.Keywords
This publication has 18 references indexed in Scilit:
- Mechanisms of nonneoplastic endocrine hyperplasia--a changing concept: a review focused on the thyroid glandEndocrine Reviews, 1995
- Enhanced expression of transforming growth factor-β1 during thyroid hyperplasia in ratsJournal of Endocrinology, 1994
- Treatment of sporadic goitre with thyroxineClinical Endocrinology, 1992
- Suppressive therapy with levothyroxinefor solitary thyroid nodulesClinical Endocrinology, 1992
- High incidence of multinodular toxic goitre in the elderly population in a low iodine intake area vs. high incidence of Graves' disease in the young in a high iodine intake area: comparative surveys of thyrotoxicosis epidemiology in East‐Jutland Denmark and IcelandJournal of Internal Medicine, 1991
- Comparison of placebo with L-thyroxine alone or with carbimazole for treatment of sporadic non-toxic goitreThe Lancet, 1990
- Transforming growth factor beta regulates thyroid growth. Role in the pathogenesis of nontoxic goiter.JCI Insight, 1989
- Does prophylactic thyroxine treatment after operation for non-toxic goitre influence thyroid size?BMJ, 1987
- Thyroid Function after Surgical Treatment of Nontoxic Goitre: A Randomized Study of Postoperative Thyroxine AdministrationActa Medica Scandinavica, 1986
- Control of growth in the rat thyroid-an example of specific desensitization to trophic hormone stimulationCellular and Molecular Life Sciences, 1983